Short description
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Description
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing its proprietary RNA interference platform.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Boston, Massachusetts, United States, North America
Founded on
January 1, 2018
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess
Sign in for full access
Founders
Anastasia Khvorova, Craig Mello, Jim Glasheen, Neil Aronin